Cochrane COVID-19 Study Register
NCT04321616

The (Norwegian) NOR Solidarity Multicenter Trial on the Efficacy of Different Anti-viral Drugs in SARS-CoV-2 Infected Patients

  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
  1. Population (9)
  2. Male and Female
  3. Acute Respiratory Distress Syndrome
  4. Hospitalization
  5. COVID-19
  6. Adult
  7. Aged (65+)
  1. Intervention (2)
  2. Remdesivir
  3. Hydroxychloroquine
  1. Comparison (1)
  2. Usual Care
  1. Outcome (7)
  2. Infection
  3. Length of ICU Stay
  4. Death
  5. Organ dysfunction
  6. SARS-CoV-2 Virus
  7. Length Of Stay
  8. Mechanical ventilation

The Efficacy of Different Anti-viral Drugs in (Severe Acute Respiratory Syndrome-Corona Virus-2) SARS-CoV-2

NCT04321616
Trial registry record
No Results
The (World Health Organization) WHO NOR- (Coronavirus infectious disease) COVID 19 study is a multi-centre, adaptive, randomized, open clinical trial to evaluate the safety and efficacy of hydroxychloroquine, remdesivir and standard of care in hospitalized adult patients diagnosed with COVID-19. This trial will follow the core WHO protocol but has additional efficacy, safety and explorative endpoints